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The strategy of placing prophylactic patches for the auto- 
matic implantable cardioverter-defibrillator (AICD) with- 
out the AICD was employed in 34 patients with coronary 
artery disease at risk for postoperative ventricular tachy- 
cardia undergoing coronary bypass graft surgery (12 pa- 
tients) or subendocardial resection (22 patients). Patients 
were selected on the basis of the presence of preoperative 
sustained ventricular tachycardia (25 patients) or ventric- 
ular fibrillation (9 patients) and absence of control of the 
arrhythmia with 3.6 -C 1.3 antiarrhythmic drugs by pro- 
grammed stimulation. Patients having subendocardial re- 
section were also selected on the basis of multiple configu- 
rations of ventricular tachycardia, inability to map the 
tachycardia or posterior wall aneurysm. 
The surgical mortality rate was 12%, with two deaths 
after coronary bypass graft surgery and two deaths after 
subendocardial resection. The AICD patches were removed 
in 1 of the 34 patients a few hours after surgery because of 
left atrial laceration and bleeding. Among 10 patients 
surviving coronary bypass surgery alone, ventricular 
arrhythmia was not inducible in 6 and in 4 it remained 
inducible postoperatively. One of the four patients with 
With refinements in patient selection and surgical tech- 
niques, including subendocardial and aneurysm resection as 
well as coronary artery bypass surgery, the role of these 
potentially curative approaches in the management of malig- 
nant ventricular tachycardia has expanded (l-10). However, 
postoperative ventricular tachycardia, either occurring 
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inducible arrhythmia had the AICD implanted with use of 
local anesthesia; the other three were treated with drugs. 
Among 20 patients surviving subendocardial resection, 
ventricular arrhythmia was noninducible in 15 and re- 
mained inducible in 5. Three of these five patients had an 
AICD implanted; the other two were treated with drugs. 
At 12 f 7 month follow-up, there were no late deaths. 
One patient with an inducible arrhythmia after coronary 
bypass surgery who was treated with drugs had a recur- 
rence 4 months after discharge and received the AICD. One 
patient without an inducible arrhythmia after suhendocar- 
dial resection had an AICD implanted for arrhythmia 
recurrence 1 year later. Thus! 6 (20%) of the 30 patients 
surviving surgery required an implanted AICD postopera- 
tively. No late complications from the patches have oc- 
curred. 
In conclusion, selective placement of prophylactic AICD 
patches in patients at risk for postoperative ventricular 
tachycardia is safe and obviates the need for subsequent 
thoracotomy in the 20% of patients who eventually need the 
AICD. 
(J Am Co11 Cardiol1989;13:1367-73) 
spontaneously or induced at electrophysiologic testing, per- 
sists in approximately one-third of patients (2,4,5), Risk 
factors for arrhythmia recurrence have been identified on the 
basis of preoperative or intraoperative clinical or electro- 
physiologic variables. These include posterior or inferior 
ventricular aneurysm location, absence of a discrete aneu- 
rysm, multiple configurations and disparate sites of ventric- 
ular tachycardia, recent myocardial infarction and the inabil- 
ity to map the arrhythmia (2,11,12). 
A standard approach to patients with postoperative 
arrhythmias includes serial drug testing and, in the absence 
of effective drugs, placement of the automatic implantable 
cardioverter-defibrillator (AICD) (13,14). It has been pro- 
posed (15.16) that subendocardial resection be routinely 
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supplemented with implantation of an AICD in all patients, 
providing additional protection against any arrhythmia re- 
currence. However, this strategy results in implantation of 
the AICD in approximately 75% of patients who remain at 
low risk for arrhythmia recurrence (16). We have undertaken 
an intermediate approach by implanting the AICD lead 
system, including patches for defibrillation and rate-sensing 
leads, in selected patients at high risk for postoperative 
arrhythmia recurrence. This procedure avoids repeat thora- 
cotomy if the AICD is needed by allowing implantation of 
the AICD with use of local anesthesia for the abdominal 
pocket. This staged approach also avoids placement of the 
AICD in patients at low risk for arrhythmia recurrence. 
Thus, only patients in whom surgery is unsuccessful who 
remain at high risk for arrhythmia recurrence identified by 
persistent arrhythmia inducibility despite antiarrhythmic 
drug treatment actually have the defibrillator placed. This 
strategy saves the costly device for future use selectively in 
high risk patients. The results of this staged approach in 
patients with malignant ventricular arrhythmias undergoing 
coronary revascularization or subendocardial resection, or 
both, are presented in this report. 
Methods 
Study patients. The study group includes 34 patients with 
coronary artery disease and preoperative spontaneous sus- 
tained ventricular tachycardia or fibrillation, undergoing 
coronary revascularization or aneurysmectomy and suben- 
docardial resection, or both. 
Electrophysiologic study. Except for seven patients with 
critical coronary lesions and unstable angina, all other 
patients had a baseline electrophysiologic study followed by 
serial electropharmacologic testing in an attempt to identify 
effective antiarrhythmic treatment. The baseline electrophys- 
iologic study was performed with the patient in the fasting 
nonsedated state. All drugs with antiarrhythmic effects had 
been discontinued for at least 5 drug half-lives. Three 
quadripolar 6F electrode catheters were introduced through 
the femoral vein and positioned fluoroscopically in the high 
lateral right atrium, across the tricuspid valve for recording 
from the His bundle, and at the right ventricular apex. 
Intracardiac recordings were stored on a magnetic tape for 
subsequent playback and analysis. Programmed cardiac 
stimulation was performed with a constant current stimula- 
tor with a 2 ms pulse duration at twice diastolic threshold. 
The stimulation protocol (17) included single and double 
extrastimuli during sinus rhythm and after three drive cycle 
lengths (600, 500, 400 ms), followed by triple extrastimuli 
during sinus rhythm and ventricular pacing at the right 
ventricular apex and outflow tract. Left ventricular stimula- 
tion was performed only if no arrhythmia was induced at the 
two right ventricular sites at the baseline study. During serial 
drug testing and follow-up electrophysiologic studies, the 
same stimulation protocol was applied. Ventricular tachy- 
cardia was defined as sustained when lasting >30 s or 
requiring termination because of hemodynamic compromise. 
Preoperative evaluation and elertrophysiologic mapping. 
All patients had right and left heart catheterization, coronary 
angiography and biplane ventriculography. Preoperative 
mapping of inducible ventricular tachycardia was performed 
in patients with hemodynamicallv stable arrhythmia, and 
was carried out in the electrophysiology laboratory with use 
of Josephson quadripolar electrode catheters (USC1 Corpo- 
ration, Billerica, MA) (18). The earliest site of diastolic 
activation was defined as the site of origin of ventricular 
tachycardia. 
Intraoperative mapping and surgical techniques. Intraop- 
erative mapping was performed under general anesthesia 
and normothermic cardiopulmonary bypass. Ventricular 
tachycardia was induced by means of an endocardial cathe- 
ter positioned at the right ventricular apex. Two epicardial 
electrodes on the right ventricular outflow tract were used to 
record reference electrograms. Local electrograms were 
recorded with use of a hand-held tripolar ring electrode or a 
roving electrode catheter moved clockwise around the myo- 
cardial scar (I 9). 
Epicardial mapping during sinus rhythm or ventricular 
tachycardia, or both, was peTformed in 8 patients, whereas 
endocardial mapping was attempted in all 22 patients with a 
discrete aneurysm undergoing aneurysmectomy. Subendo- 
cardial resection was performed at the local area of earliest 
diastolic activity recorded during ventricular tachycardia. In 
patients with a septal or papillary muscle origin of ventricu- 
lar tachycardia, cryothermia (-60°C for 2 min) was used to 
preserve the intraventrlcular septum or papillary muscle 
(20). The technique of sequential mapping-guided subendo- 
cardial resection was employed (21), with mapping and 
subendocardial resection repeated in succession until ven- 
tricular tachycardia was no longer inducible. When mapping- 
guided subendocardial resection was completed and the 
ventriculotomy site closed, the aorta was cross-clamped, 
cold cardioplegia was instituted and coronary artery bypass 
grafting was performed as necessary. 
Sahseqrrently, one .set qf .sutwcle.ss intramyocardial sens- 
ing leads and one or two epicardial dejibrillator leads 
(patches) were implanted. The electrographic amplitude and 
duration of both the rate-sensing leads and defibrillating 
patches were recorded. In patients who had only one defi- 
brillating patch implanted, no patch configuration signal was 
recorded; the intent was to use a transvenous lead (superior 
vena cava lead-spring electrode) if it was determined that the 
patient needed the defibrillator postoperatively. In patients 
who had both defibrillating leads placed, intraoperative 
defibrillation threshold testing was performed. Ventricular 
fibrillation was induced with alternating current delivered 
through a right ventricular endocardlal electrode-catheter 
and, after 10 to 15 s, defibrillation was attempted through the 
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Table 1. Clinical and Surgical Data in 34 Patients Undergoing Implantation of Prophylactic AICD Patches 
Pt LVEF Clin 
An Arrh FPS 
4 
6 
x 
9 
10 
II 
I! 
13 
14 
I5 
16 
17 
IX 
I9 
20 
21 ml 
12 58M 
23 70M 
24 70M 
25 h9M 
26 73F 
27 76M 
2x h9M 
29 60M 
30 72M 
31 h5F 
32 53M 
33 45M 
34 79F 
70M 3VD 
hhF 3VD.I.M 
6OM 3VI) 
67fZ 3VD 
53M 3VD 
68M 3VD 
45M 2VD 
74I- 3VD 
5212 3VD 
64 M 3VD 
h5M 2VD 
7XF 
70M 
7XM 
57M 
7lF 
72M 
7OM 
5xt 
5x51 
I\!D.LM 
3VD 
3VD 
I V I) 
3VD 
?VD 
3VD 
2VD 
3VII 
3VD 
IVD 
3VD 
?VD 
!VD 
2VD 
3VD.LM 
3VD.LM 
3v11 
3VD.LM 
3VI) 
?VI) 
2VI) 
3VD 
-~ - 
VI \‘I 
VT \‘I’ 
VI \:I 
VT VT 
VT \;r 
VT VT 
VF \‘T 
VF 1’7 
VT VT 
VT VT 
VT iiD 
VT VF 
VT ND 
VI v-1 
VT \‘T 
VI iiD 
VT \:F 
VI \’ 1 
VI \ I‘ 
VT VT 
VF Vl 
VF VT 
VF N D 
VT VT 
VI \‘T 
VT i:T 
VF ND 
VT VT 
VT V T 
VT ND 
VF ND 
VF VI 
VI v-1 
VF kl 
SER.CABG 
SER,CABG 
StKCABG 
SER.C.4BG 
SER.CABG 
CABG 
CABG 
CABG 
CABG 
CABG 
SER.CABG. 
.4VR 
CABG 
SER.CABG 
SER.CABG 
SER 
CABG 
SEKCABG 
SER,CABG 
SERKABG 
SbK.CABG 
VSD.MVR 
SER.CABG 
CER 
CABG 
SER.CABG 
SEK.CABG 
SEKCABG 
CABG 
CABC 
SER.CABGI 
CABG 
CABG 
SER.C.4BG 
SER 
SER.CABG 
Mapping 
-__ 
+ 
i 
t 
t 
_ 
t 
+ 
A 
I 
_- 
t 
+ 
_( 
% 
Poctop 
EPS AICD 
PI) 
t T 
i t 
PI) 
-I()-Mex) 
+(Enc) 
+: 
PI) 
+(Amio) 
+ t 
;iEnc) t 
I’D 
i t 
“Incomplete mapping: +AICD wa$ implanted I year later: dAlCD ~‘a\ implanted 4 month5 later: BAICD patches were removed a few hours after surgery 
because of lefi atrial laceration and bleeding. A = anterior: AICD = automatic implantable cardioverter-defibrillator; Amio = amiodarone; An = (left 
ventricular) aneurkm: 4VR aortlc valve replacement. CABG = coronary artery bbpas5 grafting: CAD = coronary artery disease; Clin Arrh = clinical 
arrhythmia: Enc = encamide: EPS electrophy5lologic study: F = female: I = mfermr: LM = left main: LVEF = left ventricular ejection fraction: M = male: 
Meu = mexiletine: MVR mitr;ll valve replacement: ND not done: NI -z. noninducible; P 1 procainamide; PD = perioperative death; 
Postop = postoperative: Pt = patient: Q = quinidine: SER = subendocardial re\rction: T = tocamide: VF = ventricular fibrillation: VSD = ventricular septal 
defect: VT = ventricular tachycardta: IVD = one vessel dlreahe: 2VD = two vessel disease: .3VD = three vessel disease. 
external cardioverter defibrillator. If the defibrillation subendocardial resection. Additional criteria included the 
threshold was unsatisfactory (120 J), the defibrillator presence of multiple (2) configurations of induced ventric- 
patches were repositioned and the defibrillation threshold ular tachycardia, limited or technically difficult subendocar- 
was determined by the same method. The defibrillation dial resection because of inferoposterior wall location of an 
threshold was defined as the lowest energy that termmated aneurysm or a septal or submitral origm of ventricular 
ventricular fibrillation without failure with a minimum of two tachJ(cardia and inability to perform preoperative elec- 
determinations. trophysiologic evaluation because of unstable clinical status. 
The critericr ~rscci to select patients,forproph?llncti~ AICD Postoperative evaluation. All the patients were continu- 
lrud system ir~lpl~~ntatron included absence of mappable ously monitored during the postoperative period. At 7 to 10 
arrhythmia, absence of a discrete aneurysm and incomplete days after operation, an electrophysiologic study was per- 
mapping in patients with ventricular tachycardia undergoing formed. Patients who had inducible ventricular tachycardia 
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at this study underwent serial antiarrhythmic drug testing. 
Those with persistently inducible arrhythmia on electrophar- 
macologic testing had an AICD implanted under local anes- 
thesia. 
Clinical follow-up. After discharge from the hospital, 
patients without the AICD were followed up by their refer- 
ring cardiologists and at our arrhythmia clinic every 3 
months in the first year and every 6 months thereafter. 
Evaluation of symptoms suggesttve of arrhythmia recur- 
rence was made by Holter electrocardiographic (KG) mon- 
itoring. The patients with an implanted AICD were followed 
up in our clinic every 2 months for the first year and monthly 
thereafter. During these clinic visits, in addition to routine 
clinical evaluation and follow-up, these patients had two 
magnet tests to monitor AICD discharges and battery life. 
The data are presented as mean values + SD. 
Results 
Patient characteristics (Table 1). The study group in- 
cluded 34 patients (25 men and 9 women), aged 65 2 9 years 
(range 45 to 79). All patients had coronary artery disease. 
Left ventricular ejection fraction averaged 29 ? 8% (range 16 
to 47). The presenting clinical arrhythmia was sustained 
ventricular tachycardia in 25 patients and ventricular fibril- 
lation in 9. In seven patients. preoperative electrophysiolo- 
gic evaluation was precluded by critical coronary lesions 
(left main, left main equivalent or severe three vessel dis- 
ease) and unstable angina. In the remaining 27 patients, 
primary electrophysiologic study was performed in the con- 
trol drug-free state. Sustained monomorphic ventricular 
tachycardia (mean cycle length 298 i- 67 ms) was induced in 
24 of the 27 patients. Ventricular fibrillation was induced in 
two patients, whereas in one patient with out of hospital 
cardiac arrest and a large anterior wall aneurysm, no 
arrhythmia was induced with programmed stimulation at two 
right ventricular sites or with left ventricular stimulation. 
The arrhythmias were induced with programmed ventricular 
stimulation at the right ventricular apex in 23 patients and 
with, respectively, right atrial stimulation, right ventricular 
outflow tract stimulation and left ventricular stimulation in 
the remaining 3 patients. Serial electropharmacologic testing 
was performed in the 26 patients with inducible ventricular 
arrhythmia who underwent a mean of 3.6 A 1.3 (range 2 to 6 
per patient) unsuccessful antiarrhythmic drug trials before 
surgery. 
Preoperative evaluation. Cardiac catheterization revealed 
left main coronary artery disease in 5 patients, one vessel 
disease in 3, two vessel disease in 7 and three vessel disease 
in 24. A left ventricular aneurysm was present in 25 patients, 
located anteriorly in 19 patients and inferiorly in 6 (Table 1). 
Preoperative electrophysiologic mapping during ventricular 
tachycardia was performed in nine patients. It was incom- 
plete in two patients because of the development of hemo- 
dynamic instability during the induced arrhythmia; in these 
two patients, mapping was performed during sinus rhythm. 
Surgical Procedures 
Intraoperative mapping and subendocardial resection. 
These procedures were performed in 22 patients with a left 
ventricular aneurysm and sustained monomorphic ventricu- 
lar tachycardia. Mapping was considered complete in 12 
patients. In the other 10 patients, mapping was precluded by 
nonsustained ventricular tachycardia in 3 patients, repetitive 
induction of ventricular fibrillation in 6 and no inducible 
arrhythmia in 1. In two patients with five separate configu- 
rations of ventricular tachycardia, intraoperative mapping 
was incomplete for one and two ventricular tachycardia 
configurations, respectively. Overall, 38 distinct configura- 
tions (range 1 to 5 per patient) of ventricular tachycardia 
with a mean cycle length of 380 ? 102 ms were mapped in I6 
patients. A right bundle branch block configuration was 
present in 25 and a left bundle branch block configuration in 
13 tachycardias. 
After mapping, subendocurdial resection M’US performed, 
follolzvd bv ottempts to reinduce ventricular trrchycardia. If 
ventricular tachycardia was still inducible, mapping and 
subendocardial resection were repeated until ventricular 
tachycardia could not be induced (21). In addition to suben- 
docardial resection, coronary artery bypass grafting was 
performed in 19 of the 22 patients. Patient 20 had closure of 
a postmyocardial infarction ventricular septal defect and 
mitral valve replacemeht (Table I). Patient 11 had aortic 
valve replacement for critical aortic stenosis before he died 
postoperatively of sepsis. Subendocardial resection was 
complemented by cryothermia in all patients. 
Incomplete mapping was the main reason for prophylac- 
tic AICD patch implantation in 10 of the 22 patients under- 
going suhendocnrdial resection. For the remaining I2 pa- 
tients, the decision to place prophylactic patches was based 
on the inferoposterior location of the left ventricular aneu- 
rysm in 2 patients, the presence of multiple (two to five) 
ventricular tachycardia configurations in 8 patients (2 of 
these patients also had an inferoposterior aneurysm) and 
limited subendocardial resection in 2 patients with a septal 
origin of ventricular tachycardia. 
Coronary bypass surgery alone. Of the 12 patients with 
malignant ventricular tachyarrhythmia undergoing only cor- 
onary bypass surgery, 5 were selected for implantation of 
prophylactic AICD patches on the basis of drug refractory 
ventricular tachycardia by programmed stimulation in the 
absence of a discrete left ventricular aneurysm (no mappable 
arrhythmia [ventricular fibrillation or polymorphic ventricu- 
lar tachycardia] was induced in two of these patients). Four 
patients were selected because of inability to perform pre- 
operative electrophysiologic study due to unstable angina 
and critical coronary artery disease in association with no 
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Figure 1. Flow chart of the clinical outcome of 34 
patients with malignant ventricular lachyarrhyth- 
mias who had prophylactic patches implanted at 
the time of subendocardial resection or coronary 
artery bypass surgery. AICD = automatic im- 
plantable cardioverter-defibrillator; CABG = 
coronary artery bypass grafting; EPS = elec- 
trophysiologic study; SER = subendocardial re- 
section: VT = ventricular tachycardia. *One pa- 
tient required removal of AICD patches a feu 
hours postoperatively because of left atrial lacer- 
ation and bleeding. 
1 I 
22 SER 12 CABG 
I I 
2Oopem6vewnrhrwr* 10 opemtJve wruivon3 
I I 
20 postoperative EPS 10 postopemthm EPS 
r-k r-k 
I 
1 AICD 
discrete aneurysm. The remaining three patients with critical 
coronary artery disease and left ventricular aneurysm were 
selected because of inability to perform aneurysmectomy 
due to poor contractility of nonaneurysmal segments. 
Implanted AICD lead system. The implanted system in 34 
patients included two patches in 25 patients (two large 
patches in 16 patients, one small patch and one large patch in 
8 patients and two small patches in 1 patient). Only one large 
patch was implanted in the other nine patients. Two suture- 
less intramyocardial leads used for rate sensing were im- 
planted in all patients. During intraoperative electrical test- 
ing, the patch and rate-sensing lead signals were measured. 
These included a rate-sensing signal of 14.4 2 7.5 mV in 
amplitude and 69 ? 20 ms in duration, and a patch config- 
uration signal of 9.3 2 3.1 mV in amplitude and 118 I 21 ms 
in duration. The defibrillation threshold. tested in patients 
with two patches. averaged 15.4 t 5.2 J. 
Surgical Results 
Mortality. Among the 34 patients, the surgical mortality 
rate was 12%; of the four deaths, two occurred after coro- 
nary bypass surgery and two after subendocardial resection. 
These deaths occurred at 3 days to 4 weeks postoperatively 
and were due to cardiogenic shock in two patients, sepsis in 
one patient and ischemic bowel necrosis in one patient. 
Postoperative course. The postoperative course was tran- 
siently complicated by pneumonia in 2 patients, atria1 flutter/ 
fibrillation in 10 patients and complete atrioventricular block 
in 3 patients. Two patients required hemodynamic support 
by intraaortic balloon pumping while coming off cardiopul- 
monary bypass. After subendocardial resection, one pa- 
tient’s postoperative course was complicated by left atrial 
laceration and bleeding at the AICD patch suture line, 
5 inducible VT 6 no indudbk Vl 4 inducible VT 
+-I I Gl 
3 AICD 2Drugs 0 VT recurrence 1 AICD 3bgs 
1 AICD 
requiring removal of the patches a few hours postopera- 
tively. This patient had no inducible ventricular arrhythmia 
at postoperative electrophysiologic study and required no 
antiarrhythmic therapy or AICD implant. 
Spontaneous ventricular tachyarrhythmia occurred in 
three patients postoperatively. Polymorphic ventricular 
tachycardia and ventricular fibrillation were temporally re- 
lated to procainamide use for atrial fibrillation in one patient 
after coronary bypass surgery. This patient had no inducible 
ventricular tachycardia at the postoperative electrophysio- 
logic study and was discharged without antiarrhythmic drug 
treatment. Sustained monomorphic ventricular tachycardia 
occurred after subendocardial resection id two patients, who 
also had inducible ventricular tachycardia at the postopera- 
tive electrophysiologic study and finally required an AICD 
implant or amiodarone. 
Postoperative electrophysiologic study. All 30 surgical sur- 
vivors underwent electrophysiologic study 7 to 10 days 
postoperatively. Among all studied patients, ventricular 
tachycardia was inducible in nine (30%). Among 10 patients 
surviving coronary bypass surgery, arrhythmia was not 
inducible in 6 but remained inducible in 4 (Fig. 1). One of the 
four patients with inducible arrhythmia received the AICD 
under local anesthesia after unsuccessful serial electrophar- 
macologic testing with three antiarrhythmic agents. The 
other three patients were treated with drugs (quinidine, 
procainamide plus tocainide and quinidine plus mexiletine). 
Of 20 patients surviving subendocardial resection, 15 had no 
inducible ventricular tachycardia and 5 had ventricular 
tachycardia inducible at postoperative electrophysiologic 
study. Three of these five patients had an AICD implanted 
after failing drug therapy. One of these three patients also 
remained on encainide treatment. The other two patients 
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were treated with drugs alone, including encainide and the 
combination of amiodarone and quinidine. 
Clinical Follow- Up 
During a follow-up period of 12 ? 7 months (range 3 to 
32), no late deaths have occurred. One patient with inducible 
ventricular tachycardia after coronary bypass surgery that 
was suppressed by quinidine plus mexiletine had a syncopal 
episode 4 months after hospital discharge. On repeat elec- 
trophysiologic study, ventricular tachycardia was inducible 
during drug therapy and in its absence. The patient under- 
went AICD implantation with the use of local anesthesia. 
Since then she has had three sequential AICD discharges at 
one time for symptomatic ventricular tachycardia recur- 
rence. One patient with noninducible arrhythmia after sub- 
endocardial resection had out of hospital cardiac arrest 1 
year later, and an AICD was implanted at that time. During 
the follow-up period, no late complications from the patches 
have occurred. Among the four patients who had the AICD 
implanted postoperatively before hospital discharge, two pa- 
tients had two appropriate shocks for symptomatic ventricu- 
lar tachycardia recurrence. One of these two patients also had 
three shocks during an exercise tolerance test in which his 
sinus rate exceeded the rate cutoff for the defibrillator. Thus, 
an AICD implant was needed postoperatively in six patients 
(20%) (Fig. l), and the prophylactic placement of patches 
obviated the need for subsequent thoracotomy. 
Comparison with the group without a staged procedure. 
These results can be contrasted with the results obtained in 
our institution among 65 additional patients with drug- 
refractory ventricular tachyarrhythmias who were managed 
during the time period of the 34 patients reported in this 
study. Of the 65 patients, 6 underwent surgery without 
implantation of patches, 39 received amiodarone and 20 had 
the full AICD system implanted. Of five survivors among the 
six patients with malignant ventricular arrhythmias undergo- 
ing surgery without placement of prophylactic AICD 
patches, three patients had inducible ventricular tachycardia 
postoperatively and were treated medically. None of these 
five patients had spontaneous arrhythmia recurrence over 
long-term (25 2 7 months) follow-up. Three of these six 
patients treated with surgery underwent subendocardial re- 
section (combined with coronary bypass grafting), and three 
had coronary bypass surgery alone. Prophylactic patches 
were not placed in these six patients because of the absence of 
previously defined risk factors for postoperative arrhythmias. 
Over 16 i 11 months of follow-up, there were eight 
deaths in the 39 patients receiving amiodarone therapy. 
These included two sudden deaths, three nonsudden cardiac 
deaths and three noncardiac deaths. Additionally, 11 pa- 
tients (28%) had nonfatal arrhythmia recurrences, requiring 
AICD implantation in three patients and subendocardial 
resection in two patients. 
Finalh. a group of 20 patients who wre not ctlndidutes 
for arrhythmia surgery received the full AlCD system. Over 
an 11 ? 8 month follow-up period, there have been no 
sudden deaths. but nine patients (45%) have had AlCD 
shocks for arrhythmia recurrences. 
Discussion 
Previous strategies for surgical management of ventricular 
arrhythmias. With increasing use of nonpharmacologic ther- 
apy for ventricular tachycardia, including surgery and the 
automatic implantable cardioverter defibrillator (AICD) (l- 
16), many strategies for utilizing these therapeutic modes 
have evolved. Some investigators (15,16) have advocated 
the routine use of the AICD in all patients undergoing 
subendocardial resection, whereas others will place both the 
leads and the AICD only If the arrhythmia remains inducible 
postoperatively. On the basis of clinical and electrophysio- 
logic preoperative and intraoperative factors. we selectively 
placed the AICD lead system alone in patients at high risk 
for arrhythmia recurrence. Only those patients with induc- 
ible ventricular tachycardia postoperatively who had unsuc- 
cessful antiarrhythmic drug trials eventuallv received the 
AICD. Although refinement in mapping and operative tech- 
niques and better patient selection have improved the surgi- 
cal results (7-9), there remains a 20% to 34% rate of 
arrhythmia recurrence or inducibility after subendocardial 
resection (2,4,5). Predictors df such surgical failure include 
incomplete mapping, disparate ventricular tachycardia sites, 
multiple configurations of ventricular tachycardia, absence 
of a discrete aneurysm, inferior or posterior wall site of 
ventricular tachycardia origin or recent myocardial infarc- 
tion (2,11,12). Inability to map ventricular tachycardia intra- 
operatively has been reported (5) to occur in up to 53% of 
patients with a discrete aneurysm. When there is no discrete 
aneurysm or when there is a low “excess” ejection fraction 
(poor systolic function of the nonaneurysmal ventricular 
segments), the surgical results are disappointing (2,5). Re- 
sults obtained with revascularization alone in patients with 
ventricular tachycardia related to coronary artery disease 
have been poor unless ventricular tachycardia develops in 
the setting of active ischemia in patients without prior 
myocardial infarction (9, IO). 
In patients who cannot be studied preoperatively in the 
electrophysiology laboratory because of critical coronary 
anatomy and an unstable clinical status, an assessment 
should be made intraoperatively with regard to the need for 
prophylactic patches. Of seven such patients receiving pro- 
phylactic patches in the present study, three died postoper- 
atively, no ventricular tachycardia could be induced in three 
and one patient with inducible ventricular tachycardia was 
treated medically. Because of the small number of patients 
and the mixed surgical outcome, no conclusion can thus be 
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drawn about the usefulnes\ of prophylactic patches in these 
patients. 
Staged approach in patients undergoing suhendocardial 
resection or coronary bypass. On the basis of pre- and 
intraopeldtivc Identification of patients at risk for postoper- 
ative ventricular tachycardia. we developed a staged ap- 
proach by employing the strategy of placing prophylactic 
AICD patches in selected high risk patients undergoing 
subendocaldial resection (22 patients) or coronary artery 
bypass surgery (I2 patients). The AICD lead system was 
placed without complications in 33 of 34 patients. It was 
subsequently utilized for AICD implantation under local 
anesthesia in 6 of 30 surgical survivors. obviating the need 
for an additional thoracotomy under general anesthesia with 
its attendant risks. There remains the possibility that more 
patients will use the patches for AICD implants if arrhythmia 
recurrcncc develop\ in the future. Although no complica- 
tions have occurred over a mean follow-up period of I2 
months in our patrents. this does not preclude late develop- 
ment of infection, ivnrtlictivc pericarditis UI- vthel compli- 
cations (32). Reoperation for repcat coronary arterg bypass 
surgery may also be very diecult in these patients. Addi- 
tional long-term follow-up study will be needed to evaluate 
the long-term &zy of AIC’D patches. 
Some investigator\ (15.1623) have ~~gge~txl that the full 
AICD system be implanted prophylactically at the time of 
surgery for addittonal protection. However. our strategy of 
placmg p~~phyl~tl~ pLltchc, & ~elect~veiy impMing the 
AICD avoid\ the cxpen\e and psqchosociJ costs of device 
implantation. follow-up and replacement in 7% of these 
patients (16). When pre- or mtraoperative predictors of a 
poor surgical outcome (with regard to postoperative induc- 
ibility or recurrence of ventricular tachycardia) are identi- 
fied, we recommend placement of the AICD lead system 
alone. followed by selective implantation of the device in 
patients with poctopcrative inducible arrhythmias not re- 
sponsive to antiarrhythmic itgent?. 
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